Initial results from AQUARiUS, a prospective, observational, multi-centre phase IV study assessing patient-reported outcomes (PROs) in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated with abiraterone acetate plus prednisone (AAP) or enzalutamide (ENZ)
العنوان: | Initial results from AQUARiUS, a prospective, observational, multi-centre phase IV study assessing patient-reported outcomes (PROs) in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated with abiraterone acetate plus prednisone (AAP) or enzalutamide (ENZ) |
---|---|
المؤلفون: | Guillaume Ploussard, Redas Trepiakas, A. Reid, Dominique Beal-Ardisson, Louis-Marie Dourthe, L. Dearden, Antoine Thiery-Vuillemin, Elias Pintus, Mads Hvid Poulsen, Edouard Lagneau, S. Van Sanden, A. Birtle, M Lukac |
المصدر: | Annals of Oncology. 28:v287-v288 |
بيانات النشر: | Elsevier BV, 2017. |
سنة النشر: | 2017 |
مصطلحات موضوعية: | Oncology, medicine.medical_specialty, business.industry, Abiraterone acetate, Hematology, Castration resistant, medicine.disease, Surgery, chemistry.chemical_compound, Prostate cancer, chemistry, Prednisone, Internal medicine, medicine, Enzalutamide, Observational study, Multi centre, business, medicine.drug |
تدمد: | 0923-7534 |
DOI: | 10.1093/annonc/mdx370.046 |
URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_________::47b4c648873ac6242b4874e294505bab https://doi.org/10.1093/annonc/mdx370.046 |
Rights: | OPEN |
رقم الانضمام: | edsair.doi...........47b4c648873ac6242b4874e294505bab |
قاعدة البيانات: | OpenAIRE |
كن أول من يترك تعليقا!